| Literature DB >> 35459065 |
Cristina Roldán-Jiménez1,2, Antonio I Cuesta-Vargas1,2,3, Jaime Martín-Martín1,4.
Abstract
Shoulder kinematics is a measure of interest in the clinical setting for diagnosis, evaluating treatment, and quantifying possible changes. The aim was to compare shoulder scaption kinematics between symptomatic and asymptomatic subjects by inertial sensors.Entities:
Keywords: functional assessment; inertial sensors; kinematics; shoulder
Mesh:
Year: 2022 PMID: 35459065 PMCID: PMC9029881 DOI: 10.3390/s22083081
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.847
Equivalence of the yaw, pitch and roll with the movement that they represent.
| Surface Placement | Humerus | Ulna and Radius | Scapula | Sternum |
|---|---|---|---|---|
| Anatomical Segment Represented | Humerus | Forearm | Scapula | Thorax |
| X | IN-EX | PR-SU | AN-PO | Axial rotation |
| Y | AB-AD | FL-EX | PR-RE | Flexion and extension |
| Z | FL-EX | Carrying angle | ME-LA | Lateral rotation |
AB–AD, abduction–adduction; AN–PO, anterior–posterior tiling; FL–EX, flexion–extension; IN–EX, axial rotation; ME–LA, medio-lateral rotation; PR–RE, protraction–retraction; PR–SU, pronation–supination.
Figure 1(A) Inertial sensors placement in the scapula (1), humerus (2), sternum (3) and forearm (4). (B) Mark placed on the floor to indicate frontal, lateral and scapular plane, as an intermediate line. (C) Example of SHR (°) during scaption. Blue represent humerus AB-AD. Red represents scapular PR-RE in asymptomatic control (continuous line) and pathological subject (discontinuous line). (D) Example of SHR (°/s) during scaption. Blue represent humerus AB-AD. Red represents scapular PR-RE in asymptomatic control (continuous line) and pathological subject (discontinuous line). (E) Example of SHR (m/s2) during scaption. Blue represent humerus AB-AD. Red represents scapular PR-RE in asymptomatic control (continuous line) and pathological subject (discontinuous line). SHR = Scapulo-humeral rhythm.
Humerus and Scapula kinematics variables mean (SD) in Asymptomatic subjects and Symptomatic and difference between groups.
| Mobility (°) | Velocity (°/s) | Linear Acceleration (m/s2) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | ||
| HUMERUS | AB-AD | 138.98 (13.55) | 88.80 (38.92) | 20.104 (<0.001) | 1.556 (0.864–2.267) | 84.78 (37.59) | 90.22 (155.9) | 0.015 (0.903) | −0.043 | 17.90 (2.61) | 12.28 (6.20) | 9.676 (0.004) | 1.084 (0.425–1.744) |
| FL-EX | 57.24 (27.08) | 38.62 (38.03) |
2.453 | 0.541 | 181.76 (49.63) | 106.09 (58.77) | 15.676 (<0.0001) | 1.316 (0.679–2.043) | 10.90 (2.97) | 8.73 (8.78) | 0.741 (0.395) | 0.307 | |
| IN-EX | 60.29 (50.20) | 41.55 (28.28) | 2.186 (0.148) | 0.496 | 72.15 (31.66) | 71.58 (63.01) | 0.001, (0.976) | 0.011 | 5.23 (1.76) | 5.71 (4.83) | 0.120 (0.731) | −0.12 (−0.739–0.499) | |
| SCAPULA | AN-PO | 18.85 (10.17) | 7.81 (8.66) | 11.576 (0.002) | 1.195 (0.527–1.863) | 50.19 (13.89) | 30.83 (26.49) | 5.580 (0.024) | 0.853 (0.209–1.497) | 3.15 (1.12) | 2.48 (3.74) | 0.360 (0.552) | 0.219 (−0.401–0.839) |
| ME-LA | 5.38 (3.69) | 5.47 (4.01) | 0.005 (0.946) | −0.023 (−0.641–0.595) | 44.06 (13.61) | 28.37 (19.22) | 6.351 (0.017) | 0.903 (0.256–1.55) | 4.32 (2.44) | 3.31 (3.27) | 0.893 (0.351) | 0.337 (−0.285–0.96) | |
| PR-RE | 31.89 (8.63) | 10.03 (8) | 56.663 (<0.001) | 2.654 (1.819–3.489) | 48.99 (20.37) | 27.33 (18.20) | 10.468 (0.003) | 1.139 (0.475–1.802) | 5.85 (1.43) | 4.50 (4.91) | 0.867 (0.358) | 0.337 (−0.285–0.96) | |
AB–AD: abduction–adduction; AN–PO: anterior–posterior tiling; FL–EX: flexion–extension; IN–EX: internal-external axial rotation.; ME–LA: medio-lateral rotation; PR–RE: protraction–retraction.
Forearm kinematics variables mean (SD) in Asymptomatic subjects and Symptomatic and difference between groups.
| Mobility (°) | Velocity (°/s) | Linear Acceleration (m/s2) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | |
| Carrying angle | 44.22 (47.59) | 47.17 (25.45) | 0.060 (0.809) | 0.084 | 173.03 (46.62) | 112.41 (74.21) | 6.638 (0.015) | 0.926 (0.277–1.574) | 11.64 (3.21) | 7.70 (2.39) | 17.214 (<0.001) | 1.426 (0.738–2.114) |
| FL-EX | 150.44 (10.95) | 94.26 (36.35) | 27.066 (<0.001) | 1.892 (1.156–2.628) | 116.58 (38.53) | 94.38 (68.50) | 1.079 (0.306) | 0.374 | 19.23 (3.07) | 12.98 (5.72) | 12.387 (0.001) | 1.271 (0.596–1.945) |
| PR-SU | 73.61 (62.62) | 43.70 (31.11) | 6.638 (0.015) | 0.661 (0.027–1.295) | 102.84 (26.10) | 81.73 (36.70) | 3.149 (0.085) | 0.636 (0.003–1.268) | 6.29 (1.70) | 5.59 (1.73) | 1.307 (0.261) | 0.407 |
FL–EX: flexion–extension; PR–SU: pronation–supination.
Sternum kinematics variables mean (SD) in Asymptomatic subjects and Symptomatic and difference between groups.
| Mobility (°) | Velocity (°/s) | Linear Acceleration (m/s2) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | Asymptomatic | Symptomatic | ANOVA (F, | Cohens’d (95% C.I) | |
| Lateral rotation | 15.72 (9.38) | 6.25 (8.12) | 10.285 (0.003) | 1.101 (0.44–1.762) | 24.05 (8.46) | 14.58 (9.61) | 8.852 (0.05) | 1.029 (0.373–1.684) | 2.01 (0.75) | 1.32 (0.85) | 5.952 (0.020) | 0.847 (0.203–1.491) |
| Flexion and extension | 4.71 (2.60) | 1.29 (2.14) | 18.438 (<0.001) | 1.475 (0.782–2.167) | 21.44 (5.59) | 15.30 (10.72) | 3.677 (0.63) | 0.669 (0.034–1.303) | 1.38 (0.657) | 0.65 (0.37) | 18.967 (<0.001) | 1.476 (0.783–2.168) |
| Axial rotation | 14.98 (6.34) | 5.87 (7.01) | 15.173 (<0.001) | 1.345 (0.665–2.026) | 19.43 (5.67) | 11.55 (5.33) | 17.604 (<0.001) | 1.444 (0.754–2.134) | 1.09 (0.34) | 0.73 (0.38) | 7.997 (0.008) | 0.984 (0.332–1.636) |
Correlation Person Values for symptomatic subject.
|
|
|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| −0.690 | ˂0.005 | −0.766 | 3.259 | −0.327 | 0.095 | −0.401 | 0.038 | −0.493 | 0.009 | −0.556 | ˂0.005 |
|
| −0.682 | ˂0.005 | −0.845 | 3.030 | −0.277 | 0.161 | −0.393 | 0.042 | −0.458 | 0.016 | −0.487 | 0.010 |